These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15496158)

  • 1. In vitro evidence for immune activating effect of specific AGE structures retained in uremia.
    Glorieux G; Helling R; Henle T; Brunet P; Deppisch R; Lameire N; Vanholder R
    Kidney Int; 2004 Nov; 66(5):1873-80. PubMed ID: 15496158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids.
    Glorieux G; Hsu C; De Smet R; Dhondt A; van Emmelo J; Waterloos MA; Lameire N; Plum J; Vanholder R
    Nephrol Dial Transplant; 2001 Feb; 16(2):246-52. PubMed ID: 11158396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.
    Glorieux GL; Dhondt AW; Jacobs P; Van Langeraert J; Lameire NH; De Deyn PP; Vanholder RC
    Kidney Int; 2004 Jun; 65(6):2184-92. PubMed ID: 15149331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Glycation-Modified Human Serum Albumin Evokes Alterations in Membrane and Eryptosis in Erythrocytes.
    Awasthi S; Gayathiri SK; Ramya R; Duraichelvan R; Dhason A; Saraswathi NT
    Appl Biochem Biotechnol; 2015 Nov; 177(5):1013-24. PubMed ID: 26276445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Glycation End Products Modulate Structure and Drug Binding Properties of Albumin.
    Awasthi S; Murugan NA; Saraswathi NT
    Mol Pharm; 2015 Sep; 12(9):3312-22. PubMed ID: 26281017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
    Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
    Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
    Choi YG; Lim S
    J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of proteins by methylglyoxal.
    Degenhardt TP; Thorpe SR; Baynes JW
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells.
    Rashid G; Benchetrit S; Fishman D; Bernheim J
    Kidney Int; 2004 Sep; 66(3):1099-106. PubMed ID: 15327404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products induce differential structural modifications and fibrillation of albumin.
    Awasthi S; Sankaranarayanan K; Saraswathi NT
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():60-7. PubMed ID: 27037764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric monitoring of albumin in uremia.
    Thornalley PJ; Argirova M; Ahmed N; Mann VM; Argirov O; Dawnay A
    Kidney Int; 2000 Nov; 58(5):2228-34. PubMed ID: 11044246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction.
    Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Mera K; Sakashita N; Takeya M; Ikeda T; Araki T; Nohara T; Nagai R
    Free Radic Biol Med; 2011 Apr; 50(7):883-91. PubMed ID: 21195168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
    Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
    Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.
    Lieuw-a-Fa ML; Schalkwijk CG; Engelse M; van Hinsbergh VW
    Thromb Haemost; 2006 Feb; 95(2):320-8. PubMed ID: 16493495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
    Machado AP; Pinto RS; Moysés ZP; Nakandakare ER; Quintão EC; Passarelli M
    Int J Biochem Cell Biol; 2006 Mar; 38(3):392-403. PubMed ID: 16288898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.
    Hou FF; Miyata T; Boyce J; Yuan Q; Chertow GM; Kay J; Schmidt AM; Owen WF
    Kidney Int; 2001 Mar; 59(3):990-1002. PubMed ID: 11231354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin.
    Mera K; Takeo K; Izumi M; Maruyama T; Nagai R; Otagiri M
    J Pharm Sci; 2010 Mar; 99(3):1614-25. PubMed ID: 19760671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
    Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary bread crust advanced glycation end products bind to the receptor for AGEs in HEK-293 kidney cells but are rapidly excreted after oral administration to healthy and subtotally nephrectomized rats.
    Somoza V; Lindenmeier M; Hofmann T; Frank O; Erbersdobler HF; Baynes JW; Thorpe SR; Heidland A; Zill H; Bek S; Huber J; Weigle T; Scheidler S; Busch AE; Sebeková K
    Ann N Y Acad Sci; 2005 Jun; 1043():492-500. PubMed ID: 16037271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W; Araki T; Horiuchi S; Nagai R
    J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.